Report Detail
Global Serum and Plasma Proteomics Service Market 2026 by Company, Regions, Type and Application, Forecast to 2032
- RnM4725597 |
- 03 August, 2026 |
- Global |
- 185 Pages |
- GIR |
- Service & Software
According to our (Global Info Research) latest study, the global Serum and Plasma Proteomics Service market size was valued at US$ 769 million in 2025 and is forecast to a readjusted size of US$ 1651 million by 2032 with a CAGR of 11.8% during review period.
Serum and Plasma Proteomics Service refers to specialized research services that utilize plasma and serum samples as primary biological materials and apply advanced proteomics technologies to systematically identify, quantify, and interpret circulating proteins, protein expression patterns, functional alterations, and disease-associated molecular signatures.
As one of the most accessible liquid biological sample types, plasma and serum contain extensive molecular information released from multiple tissues, organs, and immune systems. Plasma and serum proteomics provides valuable insights into disease development, treatment response, and biological regulation. Compared with genomics and transcriptomics, proteomics is closer to the functional execution layer of biology because it directly measures proteins responsible for cellular activities.
Serum and Plasma Proteomics Service typically integrates high-resolution liquid chromatography tandem mass spectrometry (LC-MS/MS), data-independent acquisition (DIA), parallel reaction monitoring (PRM), tandem mass tag (TMT) labeling, proximity extension assay (PEA), and aptamer-based proteomics technologies. Combined with artificial intelligence, bioinformatics, and multi-omics analysis, these services provide complete workflows covering sample preparation, protein profiling, quantitative analysis, biomarker discovery, and pathway interpretation.
These services are widely applied in cancer screening, immuno-oncology, cardiovascular research, neurodegenerative diseases, autoimmune disorders, metabolic diseases, infectious diseases, and pharmaceutical development. Olink provides plasma and serum-based high-throughput protein analysis services through its Analysis Services platform, supporting biomarker studies ranging from focused research projects to large-scale population studies.
Serum and Plasma Proteomics Services primarily operate under a technology-intensive life science CRO model combining advanced analytical platforms, specialized scientific expertise, and bioinformatics capabilities.
Unlike conventional laboratory testing services, this field requires integrated capabilities in biological sample processing, protein detection, large-scale data analysis, and biological interpretation. Service providers typically establish high-resolution mass spectrometry platforms, automated sample preparation systems, multiplex protein detection platforms, and computational analysis infrastructures to deliver customized proteomics solutions.
The typical workflow includes study design, plasma/serum sample receiving and quality control, protein extraction, depletion of high-abundance proteins or enrichment of target proteins, enzymatic digestion, mass spectrometry or affinity-based detection, protein quantification, statistical modeling, biomarker discovery, pathway analysis, and final scientific reporting.
The industry value chain includes upstream suppliers of mass spectrometry instruments, chromatography systems, antibodies, reagents, aptamer technologies, laboratory consumables, and bioinformatics software. The midstream consists of proteomics CRO providers, multi-omics platforms, and clinical research service companies. Downstream customers include pharmaceutical companies, biotechnology firms, hospitals, biobanks, and precision medicine organizations.
Plasma and serum proteomics services represent a high-value-added segment. Standardized plasma profiling services generally achieve gross margins of approximately 40%-60%, while advanced DIA-MS, TMT-MS, deep proteomics, and clinical cohort projects may achieve margins of 55%-75% due to higher technological complexity and analytical value.
Serum and Plasma Proteomics Services are becoming essential technology platforms for precision medicine, innovative drug discovery, and clinical translation research.
As life science research moves from genomic information toward functional protein characterization, pharmaceutical companies and research institutions increasingly require circulating protein biomarkers, disease prediction models, and treatment response evaluation. Plasma and serum provide accessible, repeatable, and scalable sample sources, making them among the most commercially valuable sample types in proteomics.
The expansion of biobanks, AI-driven protein analytics, multi-omics integration, and companion diagnostic development continues to accelerate market growth. In oncology, immunotherapy, neurodegenerative diseases, and chronic disease management, plasma and serum proteomics can reveal molecular signals that are difficult to capture through conventional approaches, supporting target discovery and precision therapies. The combination of proteomics and artificial intelligence is further improving biological data interpretation capabilities.
The market faces challenges including high technical complexity, difficulty detecting low-abundance proteins, limited standardization, and lengthy clinical validation processes.
Blood samples contain highly abundant proteins that may interfere with the detection of disease-related biomarkers. Therefore, advanced enrichment strategies, deep mass spectrometry, and highly sensitive analytical technologies are required. Data consistency between platforms, standardized workflows, and regulatory requirements will influence future commercialization.
Future demand for Serum and Plasma Proteomics Services will increasingly focus on pharmaceutical development, clinical research, and large-scale population studies.
Pharmaceutical companies will utilize plasma and serum proteomics for target discovery, mechanism-of-action studies, patient stratification, and clinical trial optimization. Biotechnology companies will increasingly rely on specialized CRO providers to reduce infrastructure investment and accelerate innovation. Research institutions and hospitals will expand applications in oncology, cardiovascular disease, neurological disorders, and immune-related diseases.
With the continued development of precision medicine and data-driven biology, service providers with high-throughput platforms, advanced analytics, proprietary databases, and global delivery capabilities will become increasingly valuable partners across the life science ecosystem.
Report Scope
This report is a detailed and comprehensive analysis for global Serum and Plasma Proteomics Service market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Serum and Plasma Proteomics Service market size and forecasts, in consumption value ($ Million), 2021-2032
Global Serum and Plasma Proteomics Service market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Serum and Plasma Proteomics Service market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Serum and Plasma Proteomics Service market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Serum and Plasma Proteomics Service
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Serum and Plasma Proteomics Service market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Olink (Thermo Fisher Scientific), SomaLogic (Illumina), Labcorp, BostonGene, CellCarta, GENEWIZ (Azenta Life Sciences), CDI Labs, Biognosys, Discovery Life Sciences, Firalis Molecular Precision, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Serum and Plasma Proteomics Service market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Plasma Proteomics Analysis Service
Serum Proteomics Analysis Service
Market segment by End User
Universities and Research Institutes
Hospitals
Pharmaceutical Companies
Others
Market segment by Research Areas
Oncology
Cardiovascular
Agriculture
Neuroscience
Other
Market segment by Application
Disease Biomarker Research
Drug Development
Clinical Research
Others
Market segment by players, this report covers
Olink (Thermo Fisher Scientific)
SomaLogic (Illumina)
Labcorp
BostonGene
CellCarta
GENEWIZ (Azenta Life Sciences)
CDI Labs
Biognosys
Discovery Life Sciences
Firalis Molecular Precision
Cell Signaling Technology (CST)
Sampled (Infinity Biologix)
APTBIO
Sinotech Genomics
Biodesix
Panome Bio
Novogene
PTM BIO
BGI Genomics
Evotec
Metware Biotechnology
MRM Proteomics
Lc-Bio Technologies
Eurofins Scientific
MtoZ-Biolabs
Creative Proteomics
Macrogen
TATAA Biocenter
OmicScouts (Momentum Biotechnologies)
Precision Biomarker Laboratories (PBL)
Shanghai OE Biotech
RxCelerate
Proteomics International
Proteome Sciences
Westlake Omics
Crown Bioscience
VProteomics
Shanghai Majorbio Bio-Pharm
Applied Biomics
Sapient Bioanalytics
Allumiqs
MS Bioworks
Shanghai Bioprofile
Cosmos Wisdom
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter Outline
Chapter 1, to describe Serum and Plasma Proteomics Service product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Serum and Plasma Proteomics Service, with revenue, gross margin, and global market share of Serum and Plasma Proteomics Service from 2021 to 2026.
Chapter 3, the Serum and Plasma Proteomics Service competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Serum and Plasma Proteomics Service market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Serum and Plasma Proteomics Service.
Chapter 13, to describe Serum and Plasma Proteomics Service research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Serum and Plasma Proteomics Service by Type
- 1.3.1 Overview: Global Serum and Plasma Proteomics Service Market Size by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Global Serum and Plasma Proteomics Service Consumption Value Market Share by Type in 2025
- 1.3.3 Plasma Proteomics Analysis Service
- 1.3.4 Serum Proteomics Analysis Service
- 1.4 Classification of Serum and Plasma Proteomics Service by End User
- 1.4.1 Overview: Global Serum and Plasma Proteomics Service Market Size by End User: 2021 Versus 2025 Versus 2032
- 1.4.2 Global Serum and Plasma Proteomics Service Consumption Value Market Share by End User in 2025
- 1.4.3 Universities and Research Institutes
- 1.4.4 Hospitals
- 1.4.5 Pharmaceutical Companies
- 1.4.6 Others
- 1.5 Classification of Serum and Plasma Proteomics Service by Research Areas
- 1.5.1 Overview: Global Serum and Plasma Proteomics Service Market Size by Research Areas: 2021 Versus 2025 Versus 2032
- 1.5.2 Global Serum and Plasma Proteomics Service Consumption Value Market Share by Research Areas in 2025
- 1.5.3 Oncology
- 1.5.4 Cardiovascular
- 1.5.5 Agriculture
- 1.5.6 Neuroscience
- 1.5.7 Other
- 1.6 Global Serum and Plasma Proteomics Service Market by Application
- 1.6.1 Overview: Global Serum and Plasma Proteomics Service Market Size by Application: 2021 Versus 2025 Versus 2032
- 1.6.2 Disease Biomarker Research
- 1.6.3 Drug Development
- 1.6.4 Clinical Research
- 1.6.5 Others
- 1.7 Global Serum and Plasma Proteomics Service Market Size & Forecast
- 1.8 Global Serum and Plasma Proteomics Service Market Size and Forecast by Region
- 1.8.1 Global Serum and Plasma Proteomics Service Market Size by Region: 2021 VS 2025 VS 2032
- 1.8.2 Global Serum and Plasma Proteomics Service Market Size by Region, (2021-2032)
- 1.8.3 North America Serum and Plasma Proteomics Service Market Size and Prospect (2021-2032)
- 1.8.4 Europe Serum and Plasma Proteomics Service Market Size and Prospect (2021-2032)
- 1.8.5 Asia-Pacific Serum and Plasma Proteomics Service Market Size and Prospect (2021-2032)
- 1.8.6 South America Serum and Plasma Proteomics Service Market Size and Prospect (2021-2032)
- 1.8.7 Middle East & Africa Serum and Plasma Proteomics Service Market Size and Prospect (2021-2032)
2 Company Profiles
- 2.1 Olink (Thermo Fisher Scientific)
- 2.1.1 Olink (Thermo Fisher Scientific) Details
- 2.1.2 Olink (Thermo Fisher Scientific) Major Business
- 2.1.3 Olink (Thermo Fisher Scientific) Serum and Plasma Proteomics Service Product and Solutions
- 2.1.4 Olink (Thermo Fisher Scientific) Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Olink (Thermo Fisher Scientific) Recent Developments and Future Plans
- 2.2 SomaLogic (Illumina)
- 2.2.1 SomaLogic (Illumina) Details
- 2.2.2 SomaLogic (Illumina) Major Business
- 2.2.3 SomaLogic (Illumina) Serum and Plasma Proteomics Service Product and Solutions
- 2.2.4 SomaLogic (Illumina) Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 SomaLogic (Illumina) Recent Developments and Future Plans
- 2.3 Labcorp
- 2.3.1 Labcorp Details
- 2.3.2 Labcorp Major Business
- 2.3.3 Labcorp Serum and Plasma Proteomics Service Product and Solutions
- 2.3.4 Labcorp Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Labcorp Recent Developments and Future Plans
- 2.4 BostonGene
- 2.4.1 BostonGene Details
- 2.4.2 BostonGene Major Business
- 2.4.3 BostonGene Serum and Plasma Proteomics Service Product and Solutions
- 2.4.4 BostonGene Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 BostonGene Recent Developments and Future Plans
- 2.5 CellCarta
- 2.5.1 CellCarta Details
- 2.5.2 CellCarta Major Business
- 2.5.3 CellCarta Serum and Plasma Proteomics Service Product and Solutions
- 2.5.4 CellCarta Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 CellCarta Recent Developments and Future Plans
- 2.6 GENEWIZ (Azenta Life Sciences)
- 2.6.1 GENEWIZ (Azenta Life Sciences) Details
- 2.6.2 GENEWIZ (Azenta Life Sciences) Major Business
- 2.6.3 GENEWIZ (Azenta Life Sciences) Serum and Plasma Proteomics Service Product and Solutions
- 2.6.4 GENEWIZ (Azenta Life Sciences) Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 GENEWIZ (Azenta Life Sciences) Recent Developments and Future Plans
- 2.7 CDI Labs
- 2.7.1 CDI Labs Details
- 2.7.2 CDI Labs Major Business
- 2.7.3 CDI Labs Serum and Plasma Proteomics Service Product and Solutions
- 2.7.4 CDI Labs Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 CDI Labs Recent Developments and Future Plans
- 2.8 Biognosys
- 2.8.1 Biognosys Details
- 2.8.2 Biognosys Major Business
- 2.8.3 Biognosys Serum and Plasma Proteomics Service Product and Solutions
- 2.8.4 Biognosys Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 Biognosys Recent Developments and Future Plans
- 2.9 Discovery Life Sciences
- 2.9.1 Discovery Life Sciences Details
- 2.9.2 Discovery Life Sciences Major Business
- 2.9.3 Discovery Life Sciences Serum and Plasma Proteomics Service Product and Solutions
- 2.9.4 Discovery Life Sciences Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
- 2.9.5 Discovery Life Sciences Recent Developments and Future Plans
- 2.10 Firalis Molecular Precision
- 2.10.1 Firalis Molecular Precision Details
- 2.10.2 Firalis Molecular Precision Major Business
- 2.10.3 Firalis Molecular Precision Serum and Plasma Proteomics Service Product and Solutions
- 2.10.4 Firalis Molecular Precision Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
- 2.10.5 Firalis Molecular Precision Recent Developments and Future Plans
- 2.11 Cell Signaling Technology (CST)
- 2.11.1 Cell Signaling Technology (CST) Details
- 2.11.2 Cell Signaling Technology (CST) Major Business
- 2.11.3 Cell Signaling Technology (CST) Serum and Plasma Proteomics Service Product and Solutions
- 2.11.4 Cell Signaling Technology (CST) Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
- 2.11.5 Cell Signaling Technology (CST) Recent Developments and Future Plans
- 2.12 Sampled (Infinity Biologix)
- 2.12.1 Sampled (Infinity Biologix) Details
- 2.12.2 Sampled (Infinity Biologix) Major Business
- 2.12.3 Sampled (Infinity Biologix) Serum and Plasma Proteomics Service Product and Solutions
- 2.12.4 Sampled (Infinity Biologix) Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
- 2.12.5 Sampled (Infinity Biologix) Recent Developments and Future Plans
- 2.13 APTBIO
- 2.13.1 APTBIO Details
- 2.13.2 APTBIO Major Business
- 2.13.3 APTBIO Serum and Plasma Proteomics Service Product and Solutions
- 2.13.4 APTBIO Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
- 2.13.5 APTBIO Recent Developments and Future Plans
- 2.14 Sinotech Genomics
- 2.14.1 Sinotech Genomics Details
- 2.14.2 Sinotech Genomics Major Business
- 2.14.3 Sinotech Genomics Serum and Plasma Proteomics Service Product and Solutions
- 2.14.4 Sinotech Genomics Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
- 2.14.5 Sinotech Genomics Recent Developments and Future Plans
- 2.15 Biodesix
- 2.15.1 Biodesix Details
- 2.15.2 Biodesix Major Business
- 2.15.3 Biodesix Serum and Plasma Proteomics Service Product and Solutions
- 2.15.4 Biodesix Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
- 2.15.5 Biodesix Recent Developments and Future Plans
- 2.16 Panome Bio
- 2.16.1 Panome Bio Details
- 2.16.2 Panome Bio Major Business
- 2.16.3 Panome Bio Serum and Plasma Proteomics Service Product and Solutions
- 2.16.4 Panome Bio Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
- 2.16.5 Panome Bio Recent Developments and Future Plans
- 2.17 Novogene
- 2.17.1 Novogene Details
- 2.17.2 Novogene Major Business
- 2.17.3 Novogene Serum and Plasma Proteomics Service Product and Solutions
- 2.17.4 Novogene Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
- 2.17.5 Novogene Recent Developments and Future Plans
- 2.18 PTM BIO
- 2.18.1 PTM BIO Details
- 2.18.2 PTM BIO Major Business
- 2.18.3 PTM BIO Serum and Plasma Proteomics Service Product and Solutions
- 2.18.4 PTM BIO Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
- 2.18.5 PTM BIO Recent Developments and Future Plans
- 2.19 BGI Genomics
- 2.19.1 BGI Genomics Details
- 2.19.2 BGI Genomics Major Business
- 2.19.3 BGI Genomics Serum and Plasma Proteomics Service Product and Solutions
- 2.19.4 BGI Genomics Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
- 2.19.5 BGI Genomics Recent Developments and Future Plans
- 2.20 Evotec
- 2.20.1 Evotec Details
- 2.20.2 Evotec Major Business
- 2.20.3 Evotec Serum and Plasma Proteomics Service Product and Solutions
- 2.20.4 Evotec Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
- 2.20.5 Evotec Recent Developments and Future Plans
- 2.21 Metware Biotechnology
- 2.21.1 Metware Biotechnology Details
- 2.21.2 Metware Biotechnology Major Business
- 2.21.3 Metware Biotechnology Serum and Plasma Proteomics Service Product and Solutions
- 2.21.4 Metware Biotechnology Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
- 2.21.5 Metware Biotechnology Recent Developments and Future Plans
- 2.22 MRM Proteomics
- 2.22.1 MRM Proteomics Details
- 2.22.2 MRM Proteomics Major Business
- 2.22.3 MRM Proteomics Serum and Plasma Proteomics Service Product and Solutions
- 2.22.4 MRM Proteomics Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
- 2.22.5 MRM Proteomics Recent Developments and Future Plans
- 2.23 Lc-Bio Technologies
- 2.23.1 Lc-Bio Technologies Details
- 2.23.2 Lc-Bio Technologies Major Business
- 2.23.3 Lc-Bio Technologies Serum and Plasma Proteomics Service Product and Solutions
- 2.23.4 Lc-Bio Technologies Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
- 2.23.5 Lc-Bio Technologies Recent Developments and Future Plans
- 2.24 Eurofins Scientific
- 2.24.1 Eurofins Scientific Details
- 2.24.2 Eurofins Scientific Major Business
- 2.24.3 Eurofins Scientific Serum and Plasma Proteomics Service Product and Solutions
- 2.24.4 Eurofins Scientific Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
- 2.24.5 Eurofins Scientific Recent Developments and Future Plans
- 2.25 MtoZ-Biolabs
- 2.25.1 MtoZ-Biolabs Details
- 2.25.2 MtoZ-Biolabs Major Business
- 2.25.3 MtoZ-Biolabs Serum and Plasma Proteomics Service Product and Solutions
- 2.25.4 MtoZ-Biolabs Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
- 2.25.5 MtoZ-Biolabs Recent Developments and Future Plans
- 2.26 Creative Proteomics
- 2.26.1 Creative Proteomics Details
- 2.26.2 Creative Proteomics Major Business
- 2.26.3 Creative Proteomics Serum and Plasma Proteomics Service Product and Solutions
- 2.26.4 Creative Proteomics Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
- 2.26.5 Creative Proteomics Recent Developments and Future Plans
- 2.27 Macrogen
- 2.27.1 Macrogen Details
- 2.27.2 Macrogen Major Business
- 2.27.3 Macrogen Serum and Plasma Proteomics Service Product and Solutions
- 2.27.4 Macrogen Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
- 2.27.5 Macrogen Recent Developments and Future Plans
- 2.28 TATAA Biocenter
- 2.28.1 TATAA Biocenter Details
- 2.28.2 TATAA Biocenter Major Business
- 2.28.3 TATAA Biocenter Serum and Plasma Proteomics Service Product and Solutions
- 2.28.4 TATAA Biocenter Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
- 2.28.5 TATAA Biocenter Recent Developments and Future Plans
- 2.29 OmicScouts (Momentum Biotechnologies)
- 2.29.1 OmicScouts (Momentum Biotechnologies) Details
- 2.29.2 OmicScouts (Momentum Biotechnologies) Major Business
- 2.29.3 OmicScouts (Momentum Biotechnologies) Serum and Plasma Proteomics Service Product and Solutions
- 2.29.4 OmicScouts (Momentum Biotechnologies) Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
- 2.29.5 OmicScouts (Momentum Biotechnologies) Recent Developments and Future Plans
- 2.30 Precision Biomarker Laboratories (PBL)
- 2.30.1 Precision Biomarker Laboratories (PBL) Details
- 2.30.2 Precision Biomarker Laboratories (PBL) Major Business
- 2.30.3 Precision Biomarker Laboratories (PBL) Serum and Plasma Proteomics Service Product and Solutions
- 2.30.4 Precision Biomarker Laboratories (PBL) Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
- 2.30.5 Precision Biomarker Laboratories (PBL) Recent Developments and Future Plans
- 2.31 Shanghai OE Biotech
- 2.31.1 Shanghai OE Biotech Details
- 2.31.2 Shanghai OE Biotech Major Business
- 2.31.3 Shanghai OE Biotech Serum and Plasma Proteomics Service Product and Solutions
- 2.31.4 Shanghai OE Biotech Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
- 2.31.5 Shanghai OE Biotech Recent Developments and Future Plans
- 2.32 RxCelerate
- 2.32.1 RxCelerate Details
- 2.32.2 RxCelerate Major Business
- 2.32.3 RxCelerate Serum and Plasma Proteomics Service Product and Solutions
- 2.32.4 RxCelerate Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
- 2.32.5 RxCelerate Recent Developments and Future Plans
- 2.33 Proteomics International
- 2.33.1 Proteomics International Details
- 2.33.2 Proteomics International Major Business
- 2.33.3 Proteomics International Serum and Plasma Proteomics Service Product and Solutions
- 2.33.4 Proteomics International Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
- 2.33.5 Proteomics International Recent Developments and Future Plans
- 2.34 Proteome Sciences
- 2.34.1 Proteome Sciences Details
- 2.34.2 Proteome Sciences Major Business
- 2.34.3 Proteome Sciences Serum and Plasma Proteomics Service Product and Solutions
- 2.34.4 Proteome Sciences Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
- 2.34.5 Proteome Sciences Recent Developments and Future Plans
- 2.35 Westlake Omics
- 2.35.1 Westlake Omics Details
- 2.35.2 Westlake Omics Major Business
- 2.35.3 Westlake Omics Serum and Plasma Proteomics Service Product and Solutions
- 2.35.4 Westlake Omics Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
- 2.35.5 Westlake Omics Recent Developments and Future Plans
- 2.36 Crown Bioscience
- 2.36.1 Crown Bioscience Details
- 2.36.2 Crown Bioscience Major Business
- 2.36.3 Crown Bioscience Serum and Plasma Proteomics Service Product and Solutions
- 2.36.4 Crown Bioscience Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
- 2.36.5 Crown Bioscience Recent Developments and Future Plans
- 2.37 VProteomics
- 2.37.1 VProteomics Details
- 2.37.2 VProteomics Major Business
- 2.37.3 VProteomics Serum and Plasma Proteomics Service Product and Solutions
- 2.37.4 VProteomics Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
- 2.37.5 VProteomics Recent Developments and Future Plans
- 2.38 Shanghai Majorbio Bio-Pharm
- 2.38.1 Shanghai Majorbio Bio-Pharm Details
- 2.38.2 Shanghai Majorbio Bio-Pharm Major Business
- 2.38.3 Shanghai Majorbio Bio-Pharm Serum and Plasma Proteomics Service Product and Solutions
- 2.38.4 Shanghai Majorbio Bio-Pharm Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
- 2.38.5 Shanghai Majorbio Bio-Pharm Recent Developments and Future Plans
- 2.39 Applied Biomics
- 2.39.1 Applied Biomics Details
- 2.39.2 Applied Biomics Major Business
- 2.39.3 Applied Biomics Serum and Plasma Proteomics Service Product and Solutions
- 2.39.4 Applied Biomics Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
- 2.39.5 Applied Biomics Recent Developments and Future Plans
- 2.40 Sapient Bioanalytics
- 2.40.1 Sapient Bioanalytics Details
- 2.40.2 Sapient Bioanalytics Major Business
- 2.40.3 Sapient Bioanalytics Serum and Plasma Proteomics Service Product and Solutions
- 2.40.4 Sapient Bioanalytics Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
- 2.40.5 Sapient Bioanalytics Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Serum and Plasma Proteomics Service Revenue and Share by Players (2021-2026)
- 3.2 Market Share Analysis (2025)
- 3.2.1 Market Share of Serum and Plasma Proteomics Service by Company Revenue
- 3.2.2 Top 3 Serum and Plasma Proteomics Service Players Market Share in 2025
- 3.2.3 Top 6 Serum and Plasma Proteomics Service Players Market Share in 2025
- 3.3 Serum and Plasma Proteomics Service Market: Overall Company Footprint Analysis
- 3.3.1 Serum and Plasma Proteomics Service Market: Region Footprint
- 3.3.2 Serum and Plasma Proteomics Service Market: Company Product Type Footprint
- 3.3.3 Serum and Plasma Proteomics Service Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Serum and Plasma Proteomics Service Consumption Value and Market Share by Type (2021-2026)
- 4.2 Global Serum and Plasma Proteomics Service Market Forecast by Type (2027-2032)
5 Market Size Segment by Application
- 5.1 Global Serum and Plasma Proteomics Service Consumption Value Market Share by Application (2021-2026)
- 5.2 Global Serum and Plasma Proteomics Service Market Forecast by Application (2027-2032)
6 North America
- 6.1 North America Serum and Plasma Proteomics Service Consumption Value by Type (2021-2032)
- 6.2 North America Serum and Plasma Proteomics Service Market Size by Application (2021-2032)
- 6.3 North America Serum and Plasma Proteomics Service Market Size by Country
- 6.3.1 North America Serum and Plasma Proteomics Service Consumption Value by Country (2021-2032)
- 6.3.2 United States Serum and Plasma Proteomics Service Market Size and Forecast (2021-2032)
- 6.3.3 Canada Serum and Plasma Proteomics Service Market Size and Forecast (2021-2032)
- 6.3.4 Mexico Serum and Plasma Proteomics Service Market Size and Forecast (2021-2032)
7 Europe
- 7.1 Europe Serum and Plasma Proteomics Service Consumption Value by Type (2021-2032)
- 7.2 Europe Serum and Plasma Proteomics Service Consumption Value by Application (2021-2032)
- 7.3 Europe Serum and Plasma Proteomics Service Market Size by Country
- 7.3.1 Europe Serum and Plasma Proteomics Service Consumption Value by Country (2021-2032)
- 7.3.2 Germany Serum and Plasma Proteomics Service Market Size and Forecast (2021-2032)
- 7.3.3 France Serum and Plasma Proteomics Service Market Size and Forecast (2021-2032)
- 7.3.4 United Kingdom Serum and Plasma Proteomics Service Market Size and Forecast (2021-2032)
- 7.3.5 Russia Serum and Plasma Proteomics Service Market Size and Forecast (2021-2032)
- 7.3.6 Italy Serum and Plasma Proteomics Service Market Size and Forecast (2021-2032)
8 Asia-Pacific
- 8.1 Asia-Pacific Serum and Plasma Proteomics Service Consumption Value by Type (2021-2032)
- 8.2 Asia-Pacific Serum and Plasma Proteomics Service Consumption Value by Application (2021-2032)
- 8.3 Asia-Pacific Serum and Plasma Proteomics Service Market Size by Region
- 8.3.1 Asia-Pacific Serum and Plasma Proteomics Service Consumption Value by Region (2021-2032)
- 8.3.2 China Serum and Plasma Proteomics Service Market Size and Forecast (2021-2032)
- 8.3.3 Japan Serum and Plasma Proteomics Service Market Size and Forecast (2021-2032)
- 8.3.4 South Korea Serum and Plasma Proteomics Service Market Size and Forecast (2021-2032)
- 8.3.5 India Serum and Plasma Proteomics Service Market Size and Forecast (2021-2032)
- 8.3.6 Southeast Asia Serum and Plasma Proteomics Service Market Size and Forecast (2021-2032)
- 8.3.7 Australia Serum and Plasma Proteomics Service Market Size and Forecast (2021-2032)
9 South America
- 9.1 South America Serum and Plasma Proteomics Service Consumption Value by Type (2021-2032)
- 9.2 South America Serum and Plasma Proteomics Service Consumption Value by Application (2021-2032)
- 9.3 South America Serum and Plasma Proteomics Service Market Size by Country
- 9.3.1 South America Serum and Plasma Proteomics Service Consumption Value by Country (2021-2032)
- 9.3.2 Brazil Serum and Plasma Proteomics Service Market Size and Forecast (2021-2032)
- 9.3.3 Argentina Serum and Plasma Proteomics Service Market Size and Forecast (2021-2032)
10 Middle East & Africa
- 10.1 Middle East & Africa Serum and Plasma Proteomics Service Consumption Value by Type (2021-2032)
- 10.2 Middle East & Africa Serum and Plasma Proteomics Service Consumption Value by Application (2021-2032)
- 10.3 Middle East & Africa Serum and Plasma Proteomics Service Market Size by Country
- 10.3.1 Middle East & Africa Serum and Plasma Proteomics Service Consumption Value by Country (2021-2032)
- 10.3.2 Turkey Serum and Plasma Proteomics Service Market Size and Forecast (2021-2032)
- 10.3.3 Saudi Arabia Serum and Plasma Proteomics Service Market Size and Forecast (2021-2032)
- 10.3.4 UAE Serum and Plasma Proteomics Service Market Size and Forecast (2021-2032)
11 Market Dynamics
- 11.1 Serum and Plasma Proteomics Service Market Drivers
- 11.2 Serum and Plasma Proteomics Service Market Restraints
- 11.3 Serum and Plasma Proteomics Service Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
12 Industry Chain Analysis
- 12.1 Serum and Plasma Proteomics Service Industry Chain
- 12.2 Serum and Plasma Proteomics Service Upstream Analysis
- 12.3 Serum and Plasma Proteomics Service Midstream Analysis
- 12.4 Serum and Plasma Proteomics Service Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Serum and Plasma Proteomics Service. Industry analysis & Market Report on Serum and Plasma Proteomics Service is a syndicated market report, published as Global Serum and Plasma Proteomics Service Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Serum and Plasma Proteomics Service market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
